Sodium Benzoate/Sodium phenylacetate

苯甲酸钠/苯乙酸钠

Report date: 2026/03/16 20:01:47

Base Information

Drug NameSodium Benzoate/Sodium phenylacetate
Drug Alias Name苯乙酸钠/苯甲酸钠Sodium phenylacetate/Sodium BenzoateSodium Benzoate and Sodium phenylacetatesodium phenylacetate and sodium benzoatesodium phenylacetate + sodium benzoate +[8] 
ClassificationSmall molecules
Mechanisms of ActionD-amino-acid oxidase inhibitors
TargetsD-amino-acid oxidase
Therapy Area/IndicationsHyperammonemiaUrea Cycle Disorders, Inborn
Global Approved IndicationsHyperammonemiaUrea Cycle Disorders, Inborn
Approved Indications in ChinaHyperammonemia
Original Approved Country/TerritoryUnited States
Original Approved Date1987/12/23
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsYes Sodium phenylacetateSodium Benzoate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesB Braun Medical
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Wotai Biomedical Co LtdBausch Health Companies Inc
Inactive CompaniesTakeda Pharmaceutical Co LtdB Braun Medical
Active IndicationsHyperammonemiaUrea Cycle Disorders, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG